<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05095870</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2021/II-02</org_study_id>
    <secondary_id>IRB 21.09.30</secondary_id>
    <nct_id>NCT05095870</nct_id>
  </id_info>
  <brief_title>Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies</brief_title>
  <acronym>CANVAS</acronym>
  <official_title>Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS (Cerebellar Ataxia With Neuropathy and Vestibular Areflexia Syndrome) Neuronopathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebellar ataxia with neuropathy and bilateral areflexia syndrome (CANVAS) is a late onset&#xD;
      neurodegenerative disorder with a slowly progressive ataxia. It's genetic causative etiology&#xD;
      with an autosomal recessive inheritance has a recent discovery.&#xD;
&#xD;
      It is clinically characterized by impaired visually enhanced vestibulo-ocular reflex,&#xD;
      although patients commonly present with imbalance as a main concern, associated with sensory&#xD;
      complaints. It has been demonstrated that sensory impairment in CANVAS patients is due to&#xD;
      degeneration of dorsal root with abnormal sensory nerve conduction.&#xD;
&#xD;
      Previously defined diagnostic criteria included cerebellar atrophy on brain MRI, neuronopathy&#xD;
      on electrophysiological studies and negative genetic testing for other inherited ataxia&#xD;
      syndromes like Friedriech ataxia and spinal cerebellar ataxia (SCA).&#xD;
&#xD;
      Peripheral nerve ultrasound is a noninvasive technique, able to identify abnormal peripheral&#xD;
      nerves with underlying injuries and specific sonographic characteristics. Pelosi et al&#xD;
      established that patients with CANVAS have a smaller nerve cross sectional area (CSA)&#xD;
      compared to healthy individuals and/ or axonal neuropathies.&#xD;
&#xD;
      The main objective of this study was to obtaine a detailed description of peripheral nerves&#xD;
      in consecutive patients with CANVAS syndrome followed in theneurology department of the&#xD;
      Universitary Hospital of Nimes (France), using conventional electrophysiology and peripheral&#xD;
      nerve ultrasound.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>median ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of median nerve ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ulnar nerve at wrist ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve at wrist, ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mid-arm ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, mid-arm, ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>elbow ultrasound</measure>
    <time_frame>baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, elbow, ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ultrasound</measure>
    <time_frame>Day of the evaluation</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of ulnar nerve, mid-forearm, ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>radial nerve ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of radial nerve ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>superficial radial branch nerve ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of superficial radial branch nerve ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C5, C6 ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of C5, C6 roots ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sural nerve ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of sural nerve ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>superficial fibular nerve ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of superficial fibular nerve ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>popliteus ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of popliteus tibial nerve at ankle ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>tibial ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of tibial nerveat ankle ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fibular ultrasound</measure>
    <time_frame>Baseline</time_frame>
    <description>Comparison of axial cross-sectional area to Bilateral exploration of fibular nerve at the neck ultrasound</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Neuropathy</condition>
  <condition>Cerebellar Ataxia</condition>
  <condition>Neurodegenerative Diseases</condition>
  <arm_group>
    <arm_group_label>CANVAS Patients</arm_group_label>
    <description>Patient with a CANVAS diagnosis with genetic evidence (RFC1+)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>Patient with axonal sensory-motor or pure sensitive neuropathy confirmed by electroneuromyography</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Pure observational study</description>
    <arm_group_label>CANVAS Patients</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive patients with CANVAS syndrome followed in our neurology department, using&#xD;
        conventional electrophysiology and peripheral nerve ultrasound.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        CANVAS Patients :&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients followed at the University Hospital of Nîmes between 2018-2021&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Diagnosis of CANVAS with genetic evidence (RFC1+)&#xD;
&#xD;
          -  Diagnosis of neuronopathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Chronic polyradiculoneuritis or other demyelinating neuropathy&#xD;
&#xD;
        Control group, inclusion criteria :&#xD;
&#xD;
        Patient with axonal sensory-motor or pure sensory neuropathy confirmed by electro&#xD;
        neuromyography, and concordant with the clinic.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anissa MEGZARI</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nīmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioana Maria ION</last_name>
    <phone>+ 33 622 920 361</phone>
    <email>ioanamaria.ion@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30129</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioana Maria ION</last_name>
      <phone>+ 33 622 920 361</phone>
      <email>ioanamaria.ion@chu-nimes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 1, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ataxia</mesh_term>
    <mesh_term>Cerebellar Ataxia</mesh_term>
    <mesh_term>Neurodegenerative Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

